Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia
about
Testosterone plus low-intensity physical training in late life improves functional performance, skeletal muscle mitochondrial biogenesis, and mitochondrial quality control in male miceThe renin-angiotensin system and prevention of age-related functional decline: where are we now?Battery of behavioral tests in mice that models age-associated changes in human motor function.Optimizing the benefits of exercise on physical function in older adults.Sarcopenia and physical frailty: two sides of the same coinTranslational geroscience: emphasizing function to achieve optimal longevityMulti-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.Of mice and men: the benefits of caloric restriction, exercise, and mimetics.Successful aging: Advancing the science of physical independence in older adults.Hypertension and aging.Toward exercise as personalized medicine.Testosterone improves the regeneration of old and young mouse skeletal muscleAngiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.Rapamycin Versus Intermittent Feeding: Dissociable Effects on Physiological and Behavioral Outcomes When Initiated Early and Late in Life.Antihypertensive Use and the Effect of a Physical Activity Intervention in the Prevention of Major Mobility Disability Among Older Adults: The LIFE Study.Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity.Sarcopenia: Relocating the Forest among the Trees.Comparative Approaches to Understanding the Relation Between Aging and Physical Function.Antihypertensive monotherapy or combined therapy: which is more effective on functional status?Muscle function decline and mitochondria changes in middle age precede sarcopenia in mice.Age-Related Changes in Skeletal Muscle of Cattle.
P2860
Q27332135-E9E6A620-75B0-4AF4-BD6B-48E963F300BEQ28085528-A02C7ED2-502C-432B-97E4-56F1534306DBQ30579295-D49EBC16-B858-4587-A8CB-4C5574BA6157Q33779905-C15171BB-4AC2-47E3-9E22-61985B32B2B6Q33958411-1B147E0F-B003-4566-BE50-66ED364284C5Q34461132-C16D1959-CEBE-4906-A97E-C2337C524526Q35908858-E261EDC3-50CA-44E3-8FEC-DD3AAE923DC6Q35973671-BFFDEDDE-DC86-413B-95DD-84613F811033Q36322590-BEC5C415-09AA-434C-84C5-C5E5E00B478BQ36623143-734C64D6-DC86-487F-9F37-223426431516Q36678544-1D692F1B-3CF0-4238-B580-90A9FC2662B8Q36686910-E56E7125-4CE0-4FB8-969E-102A1AC6CCF5Q36764607-30F36672-76AC-48DA-BD39-B74212CD7B85Q37000448-D8CE59FD-780D-496B-A23D-7FFDD304BC26Q37000459-54926B1D-718A-4660-8A85-CF8A714E7A6EQ38339672-73CAA31D-E1F1-4EFF-9836-B99C0DA73CBDQ38645615-E07AAC42-93B6-4090-A02F-9B8696675871Q41648182-99C40A74-FEDD-40CD-8DA3-5ECC3B621E95Q48237130-1CBA7BED-EB04-4C96-94AB-4A84B411F25FQ50119790-DA7A3459-6FDF-449F-B2F5-8C80C92081A5Q50260921-70254CF6-5CCA-4882-8EA1-9CC4B825BEBC
P2860
Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Usefulness of preclinical mode ...... e interventions for sarcopenia
@ast
Usefulness of preclinical mode ...... e interventions for sarcopenia
@en
type
label
Usefulness of preclinical mode ...... e interventions for sarcopenia
@ast
Usefulness of preclinical mode ...... e interventions for sarcopenia
@en
prefLabel
Usefulness of preclinical mode ...... e interventions for sarcopenia
@ast
Usefulness of preclinical mode ...... e interventions for sarcopenia
@en
P2093
P2860
P356
P1476
Usefulness of preclinical mode ...... e interventions for sarcopenia
@en
P2093
Christiaan Leeuwenburgh
Christy S Carter
Drake Morgan
Emanuele Marzetti
Philip J Scarpace
Thomas C Foster
Todd Manini
P2860
P356
10.1093/GERONA/GLR042
P407
P577
2011-06-02T00:00:00Z